Filing Details
- Accession Number:
- 0001415889-24-001821
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-25 17:50:36
- Reporting Period:
- 2024-01-23
- Accepted Time:
- 2024-01-25 17:50:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649094 | Vaxcyte Inc. | PCVX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1258693 | Grant Pickering | C/O Vaxcyte, Inc. 825 Industrial Road, Ste. 300 San Carlos CA 94070 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-01-23 | 3,000 | $0.04 | 378,814 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-01-23 | 12,000 | $1.79 | 390,814 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-01-23 | 2,938 | $63.22 | 387,876 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-01-23 | 10,023 | $63.95 | 377,853 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-01-23 | 2,039 | $64.78 | 375,814 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-01-23 | 3,000 | $0.00 | 3,000 | $0.04 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2024-01-23 | 12,000 | $0.00 | 12,000 | $1.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 663 | 2025-04-23 | No | 4 | M | Direct | |
| 105,225 | 2027-05-17 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 151,286 | Indirect | By Children's Trust |
| Common Stock | 151,286 | Indirect | By Children's Trust |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on June 26, 2023.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $62.625 to $63.61. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $63.66 to $64.625. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The price reported is a weighted-average price. The shares were sold at prices ranging from $64.70 to $64.975. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Shares are held directly by a trust for the benefit of the Reporting Person's daughter.
- Shares are held directly by a trust for the benefit of the Reporting Person's son.
- Stock Option is fully vested and exercisable.
Billionaire Hedge Funds
